|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01696 SISRAM MED
Nominal 
4.540 +0.120 (+2.715%) | 2024/12 - Final USD(K$) | %Chg (Compare to Final) | 2023/12 USD(K$) | 2022/12 USD(K$) | 2021/12 USD(K$) | 2020/12 USD(K$) | |
| Turnover | 349,112 | -2.833% | 359,292 | 354,480 | 294,294 | 162,095 |
| Cost of Sales | (132,432) | -5.248% | (139,767) | (152,254) | (127,433) | (71,794) |
| Gross Profit | 216,680 | -1.296% | 219,525 | 202,226 | 166,861 | 90,301 |
| 2024/12 - Final USD(K$) | %Chg (Compare to Final) | 2023/12 USD(K$) | 2022/12 USD(K$) | 2021/12 USD(K$) | 2020/12 USD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 30 | -- | (421) | (521) | (307) | 0 | |
| Profit / (Loss) before Taxation | 32,541 | -12.359% | 37,130 | 44,242 | 41,672 | 16,662 | |
| Taxation | (3,775) | -10.799% | (4,232) | (4,162) | (9,152) | (1,982) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (3,640) | 160.186% | (1,399) | 90 | (1,275) | (1,336) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 25,126 | -20.232% | 31,499 | 40,170 | 31,245 | 13,344 | |
| 2024/12 - Final USD(K$) | %Chg (Compare to Final) | 2023/12 USD(K$) | 2022/12 USD(K$) | 2021/12 USD(K$) | 2020/12 USD(K$) | |
| Net Finance Costs / (Income) | 1,665 | -9.609% | 1,842 | 1,359 | 1,462 | 291 |
| Depreciation & Amortisation | 17,306 | 21.574% | 14,235 | 12,402 | 12,285 | 10,462 |
| Directors' Emoluments | -- | -- | 1,681 | 2,565 | 1,711 | 869 |
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | 5.360 | -20.475% | 6.740 | 8.620 | 6.900 | 3.020 |
| DPS (cts) | 1.622 | -- | 2.020 | 2.204 | 2.008 | 0.900 |
| Dividend Payout Ratio (%) | 30.257% | -- | 29.973% | 25.574% | 29.106% | 29.801% |
| Cash flow per share ($) | -- | -- | 0.094 | 0.047 | 0.072 | 0.058 |
| NBV per share ($) | 0.991 | -- | 0.966 | 0.922 | 0.863 | 0.751 |
| Remarks: | Real time quote last updated: 21/03/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | USD 25,126,000 |
| %Change | -20.232% |
| EPS / (LPS) | USD 0.054 |
| NBV Per Share ($) | USD 0.991 |